Neovacs SA (France) Market Value
| ALNEV Stock | EUR 0.0002 0.00 0.00% |
| Symbol | Neovacs |
Neovacs SA 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Neovacs SA's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Neovacs SA.
| 10/23/2024 |
| 11/22/2024 |
If you would invest 0.00 in Neovacs SA on October 23, 2024 and sell it all today you would earn a total of 0.00 from holding Neovacs SA or generate 0.0% return on investment in Neovacs SA over 30 days. Neovacs SA is related to or competes with Kalray SA, and OSE Pharma. Neovacs S.A., a biotechnology company, focuses on the development of therapeutic vaccines for the treatment of autoimmun... More
Neovacs SA Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Neovacs SA's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Neovacs SA upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.11) | |||
| Maximum Drawdown | 100.0 | |||
| Value At Risk | (33.33) | |||
| Potential Upside | 33.33 |
Neovacs SA Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Neovacs SA's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Neovacs SA's standard deviation. In reality, there are many statistical measures that can use Neovacs SA historical prices to predict the future Neovacs SA's volatility.| Risk Adjusted Performance | (0.07) | |||
| Jensen Alpha | (1.68) | |||
| Total Risk Alpha | (4.00) | |||
| Treynor Ratio | 0.6646 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Neovacs SA's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Neovacs SA Backtested Returns
Neovacs SA has Sharpe Ratio of -0.0722, which conveys that the firm had a -0.0722% return per unit of risk over the last 3 months. Neovacs SA exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Neovacs SA's Mean Deviation of 11.0, risk adjusted performance of (0.07), and Standard Deviation of 18.24 to check out the risk estimate we provide. The company secures a Beta (Market Risk) of -2.9, which conveys a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Neovacs SA are expected to decrease by larger amounts. On the other hand, during market turmoil, Neovacs SA is expected to outperform it. At this point, Neovacs SA has a negative expected return of -1.31%. Please make sure to verify Neovacs SA's information ratio, potential upside, as well as the relationship between the Potential Upside and day median price , to decide if Neovacs SA performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.00 |
No correlation between past and present
Neovacs SA has no correlation between past and present. Overlapping area represents the amount of predictability between Neovacs SA time series from 23rd of October 2024 to 7th of November 2024 and 7th of November 2024 to 22nd of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Neovacs SA price movement. The serial correlation of 0.0 indicates that just 0.0% of current Neovacs SA price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.0 | |
| Spearman Rank Test | -0.13 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Neovacs SA lagged returns against current returns
Autocorrelation, which is Neovacs SA stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Neovacs SA's stock expected returns. We can calculate the autocorrelation of Neovacs SA returns to help us make a trade decision. For example, suppose you find that Neovacs SA has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Neovacs SA regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Neovacs SA stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Neovacs SA stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Neovacs SA stock over time.
Current vs Lagged Prices |
| Timeline |
Neovacs SA Lagged Returns
When evaluating Neovacs SA's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Neovacs SA stock have on its future price. Neovacs SA autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Neovacs SA autocorrelation shows the relationship between Neovacs SA stock current value and its past values and can show if there is a momentum factor associated with investing in Neovacs SA.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Neovacs Stock Analysis
When running Neovacs SA's price analysis, check to measure Neovacs SA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Neovacs SA is operating at the current time. Most of Neovacs SA's value examination focuses on studying past and present price action to predict the probability of Neovacs SA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Neovacs SA's price. Additionally, you may evaluate how the addition of Neovacs SA to your portfolios can decrease your overall portfolio volatility.